Journal of the Neurological Sciences issue 481 now available

Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis

Published online: December 25, 2025

A new systematic review and meta-analysis examines the long-term burden of neuromuscular diseases (NMDs) following COVID-19, addressing ongoing uncertainty around their prevalence and recovery trajectories. Drawing on studies with follow-up extending to 24 months, the review evaluates fourteen specific neuromuscular conditions and related symptoms in COVID-19 survivors.

Read the full article for a comprehensive overview of how different neuromuscular conditions evolve after COVID-19 and which symptoms may require longer-term clinical attention.

Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut syndrome (LennoVig): A single center randomized double-blind placebo-controlled trial

Published online: December 30, 2025

A new randomized, double-blind, placebo-controlled trial evaluates the safety and efficacy of adjunctive vigabatrin in children with Lennox-Gastaut syndrome (LGS), a severe developmental epileptic encephalopathy that is often resistant to treatment. The study assessed seizure outcomes over 12 weeks in patients aged 2–18 years receiving vigabatrin or placebo alongside standard therapy.

Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network

Published online: January 7, 2026

A large longitudinal cohort study examines the long-term risks associated with corticosteroid use in patients with myasthenia gravis (MG), drawing on over two decades of data from the U.S. Veterans Affairs Health Care Network. The study compares patients with MG to matched non-MG controls to assess how corticosteroid exposure influences the development of common comorbidities over time.

Vestibulo-ocular reflex suppression: A practical guide for neurologists

Published online: January 2, 2026

A new practical review highlights vestibulo-ocular reflex suppression (VORS) testing as a valuable yet underused bedside tool for evaluating patients with dizziness. While clinical assessment often centres on the head impulse test, the review shows how impaired VORS can point to central vestibular dysfunction, particularly involving the cerebellum.